Study population and eligibility criteria We reasoned to choose as patients cohort a group of healthy obese women with polycystic ovary syndrome (PCOS) that have increased metabolic risk, in order to avoid any other concomitant clinical feature as a confounding factor, and potentially affecting the results of our study
Int J Endocrinol
The most common issues are nausea, constipation, diarrhea, bloating, reflux, and occasional vomiting
Before starting weight loss injections, you need comprehensive laboratory evaluation including liver function tests (ALT, AST, bilirubin, albumin), metabolic panel, hemoglobin A1c, lipid panel, and non-invasive fibrosis assessment using the FIB-4 score
Patients receiving b12 for pernicious anemia, neurological conditions, or documented deficiency do not report nausea improvement unless their nausea stemmed from the deficiency itself